@ncmbm
NCMBM, hosted at the University of Oslo, is an international research centre in interdisciplinary molecular biosciences and medicine research. NCMBM is the Norwegian node of the Nordic EMBL Partnership for Molecular Medicine. www.med.uio.no/ncmbm/english
🌙 Sleep Awareness Month – Myth vs Fact
What we think we know about sleep isn’t always right.
Alessandro Arena from @charlotteboccara.bsky.social separate myths from evidence and improve sleep health across the lifespan.
@embl.org @esrs.bsky.social @nordicembl.bsky.social
💡Find out more about the work of ESRS 👉 esrs.eu
Follow along this month as we explore why sleep matters, from developing brains to lifelong health. 🌙
@embl.org @nordicembl.bsky.social
🌙 March is Sleep Awareness Month!
We’re spotlighting the European Sleep Research Society and @charlotteboccara.bsky.social group at @ncmbm.bsky.social.
@esrs.bsky.social connects Europe’s sleep community.
🧠 Boccara’s team studies how sleep shapes brain & metabolic development.
📢 Hiring! Our group @ncmbm.bsky.social seeks a Research Scientist contributing to:
• Reproducible pipelines for large-scale genomics
• cisreg signature analysis in breast cancer
• Continued development of JASPAR
• Cross-disciplinary collaboration
Apply now 👉
www.jobbnorge.no/en/available...
👩🔬 We are celebrating International Girls and Women in STEM Day 🎉!
Charlotte Boccara, group leader @ncmbm.bsky.social has been sharing her story and research on sleep in an article in Apollon.
💡To all girls and women in STEM: Let your curiosity lead the way!
tinyurl.com/3m7bz7su
@embl.org @uio.no
We are delighted to announce that Janna Saarela, Director of @ncmbm.bsky.social, has been appointed as the new Speaker of the @nordicembl.bsky.social!
Read about her priorities and vision here👉https://tinyurl.com/yc3ytvez
@embl.org @dandrite.bsky.social @mimsumea.bsky.social @fimm-uh.bsky.social
@amathelier.bsky.social from NCMBM, says: “ I am very proud to see JASPAR officially recognised as a Core Data Resource by ELIXIR and it is wonderful to see JASPAR join the ranks of other well-established European resources."
Read more about this achievement: tinyurl.com/4r6zntvw
Picture of Anthony Mathelier on a blue background. The logos for JASPAR and for ELIXIR Cor Data Resource have been added. The text title states "JASPAR recognised as an ELIXIR Core Resource".
📣JASPAR has been added to ELIXIR Core Data Resources! hashtag#ELIXIRCDRs are European hashtag#lifescience data resources that are fundamentally important 🙌 to biological and biomedical research and long-term preservation of biological data.
Check @ELIXIREurope ’s news release: tinyurl.com/ypjnfuum
Interested in rare disease clinical trials? Check out the announcement below from @realised-ihi.bsky.social ! They have a great programme in store for you!
@uio.no @embl.org @nordicembl.bsky.social
Together, these approaches create a uniquely powerful platform for exploring how transcription factors interpret the genome.”
📰 Read the full story: www.med.uio.no/ncmbm/englis...
Congrats to the entire JASPAR community for driving this resource forward to shape the future of regulatory genomics!
💬 Joint first authors @ievarau.bsky.social and @damlaob.bsky.social remark:
“This release marks a major milestone for JASPAR. Deep learning models now sit alongside the classical collections, letting researchers build on two decades of curated knowledge while harnessing modern computational power.”
🔍 What’s new?
For the first time, JASPAR now hosts a Deep Learning Collection running alongside its trusted classical PFM-based motif collections. This marks a transformative step in how researchers can explore transcription factor (TF) binding and gene regulation.
🚀 JASPAR goes Deep Learning! A major milestone for regulatory genomics.
Excited to share the newest JASPAR 2026 update, led by @amathelier.bsky.social from @ncmbm.bsky.social and supported by an international network of contributors across ten countries!
📄Publication: doi.org/10.1093/nar/...
Picture of Anthony with the purple Clarivate banner stating "Highly Cited Researcher 2025.
🎉 Congratulations to @amathelier.bsky.social for being recognised as being in the top 1% on the world's most highly cited researchers by @clarivate.com!
This highlights the contribution he has made to Biology and Biochemistry over the past 11 years!
@nordicembl.bsky.social @embl.org @uio.no
Beehive-like structure with the hexagons being different shades of blue. It states "Newsletter October 2025" in yellow on the right-hand side.
📜 It's @ncmbm.bsky.social Newsletter time! You can now find out what we have been up to this past month; enjoy the read!
🧷 You can read it here 👉https://pub.dialogapi.no/v/c08f518b-1810-4084-848f-a29ba87d6fd0
@nordicembl.bsky.social @embl.org
📣 On the look out for a postdoctoral position in the Nordics? Fascinated by behavioural and systems neuroscience?
Charlotte Boccara from @ncmbm.bsky.social is recruiting.
Details of the 3-year postdoctoral position can be found 👉 www.jobbnorge.no/en/available...
NCMBM marking Black History Month as part of its Tuesday Seminar series with Melaku Tadesse.
@uio.no @embl.org @nordicembl.bsky.social @amathelier.bsky.social
Welcome Charlene!
Now accepting workshop proposals for Oslo Bioinformatics Workshop Week 2025, hosted by @uio.no Dec 8–12, 2025. Explore last year's program: www.mn.uio.no/bils/english....
Submit your proposal here: nettskjema.no/a/539526
Supported by @uio.no, UiO: Life Science, @ncmbm.bsky.social, @ocbe.bsky.social
📢Last chance today! We are looking forward to receiving your applications👇!
This week at the RealiseD workshop, we explored how playbooks can drive innovation in #ClinicalTrial design for rare & ultra- #RareDiseases.
EATRIS co-leads WP9 with SANOFI, developing tools, workflows & decision trees for smarter, more efficient trials.
👉 More here: https://loom.ly/fpIZ7uI
Katalin Ferenc presenting how to improve bioinformatics software quality through teamwork.
Great talk by Kata Ferenc on improving bioinformatics software quality through teamwork, sharing how we’ve approached this at @ncmbm.bsky.social
It sparked discussion on taking action within our Bioinformatics in Life Science initiative at @uio.no @biovitenskap.bsky.social
doi.org/10.1093/bioi...
📅 Deadline: 8 September 2025
🔗 Apply here: www.jobbnorge.no/en/available...
@embl.org @nordicembl.bsky.social
⏰ One week left to apply!
@ncmbm.bsky.social is recruiting 1–2 early-career EMBL-style Group Leaders!
💡“We need group leaders who can bridge research and innovation to advance Norway’s life science sector – this is a rare opportunity to do just that.” Jens Petter Berg, UiO.
📜 It's @ncmbm.bsky.social Newsletter time! You can now find out what we have been up to since our last edition in June - we are delighted to celebrate our research and the great people that make it happen!
🧷 You can read it here 👉https://pub.dialogapi.no/v/6eaa352c-6740-4a14-bd43-f60166ae2990
The findings not only help patients with this rare immune disorder, but may also provide insights relevant to autoimmunity, common inflammatory diseases and cancer immunotherapy.
📜 Read more about the study 👉 tinyurl.com/mrhkm4fu
This @nordicembl.bsky.social collaboration led by Saarela Janna and Meri Kaustio combined genomic analysis, functional immunology and CRISPR-based validation to uncover how HPK1, the gene product of MAP4K1, acts as a brake on T cell activation and function.
📣 Publication alert!
🔬 New genetic discovery from @FIMM and NCMBM: MAP4K1 as a key regulator of immune balance
👩🔬 Researchers from the @fimm-uh.bsky.social and @ncmbm.bsky.social have identified MAP4K1 as a novel gene behind immune dysregulation.
📄 Read the full article: doi.org/10.1016/j.ja...
⌛Less than 2 weeks left to apply!
We are looking for 1-2 new Group Leaders to launch ambitious, internationally recognised research programmes!
All the info can be found 👉 www.jobbnorge.no/en/available...
📅Deadline Sept 8th, 2025!
🧬 We offer:
- Up to 9 years of core funding + attractive start-up package
- Access to the @nordicembl.bsky.social network, facilities & expertise
📍 Oslo, Norway
🗓 Deadline: 8 September 2025
👉 Apply here: www.jobbnorge.no/en/available...
